Publicaciones en colaboración con investigadores/as de Joint Clinical Research Centre (3)

2023

  1. Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

    eClinicalMedicine, Vol. 60

2018

  1. Microbial translocation does not drive immune activation in ugandan children infected with HIV

    Journal of Infectious Diseases, Vol. 219, Núm. 1, pp. 89-100

2016

  1. Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): An open-label, parallel-group, randomised controlled trial

    The Lancet Infectious Diseases, Vol. 16, Núm. 2, pp. 169-179